| Anderson, Karen S. |
Arizona State University-Tempe Campus
United States |
Southwest EDRN Clinical Validation Center for Head and Neck Cancer |
1U01CA281660-01 |
|
Wendy Wang, Ph.D., M.Sc. |
| Fahrmann, Johannes F |
University Of Tx Md Anderson Can Ctr
United States |
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer |
1U01CA282216-01 |
|
Claire Zhu, Ph.D. |
| Simeone, Diane M |
New York University School Of Medicine
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
1U01CA282272-01 |
PAR-21-334 (U01 Clinical Trial Optional) |
|
| Villanueva, Augusto |
Icahn School Of Medicine At Mount Sinai
United States |
Liquid biopsy and radiomics for liver cancer surveillance |
1U01CA283931-01 |
|
Matthew Young, Ph.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
1U01CA283935-01 |
|
Matthew Young, Ph.D. |
| Lee, Hakho |
Massachusetts General Hospital
United States |
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array |
1U01CA284982-01 |
|
|
| Zhou, Xianghong Jasmine |
University Of California Los Angeles
United States |
Multi-cancer early detection using cell-free DNA methylome analysis |
1U01CA285010-01 |
|
|
| Kuhn, Peter |
University Of Southern California
United States |
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma |
1U01CA285013-01 |
|
|
| Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis |
1U01CA288375-01 |
|
|
| Alexandrov, Ludmil B |
University Of California, San Diego
United States |
Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition |
1U01CA290479-01 |
|
Wendy Wang, Ph.D., M.Sc. |